An Active-Control, Randomized, Prospective, Multicenter, Phase-III Comparative Clinical Study to investigate, Efficacy, Safety and Tolerability of Linezolid 1200mg SR Tablet OD when compared with Linezolid 600mg Tablet BD in subjects suffering with Uncomplicated Skin and Soft Tissue Infections

Trial Profile

An Active-Control, Randomized, Prospective, Multicenter, Phase-III Comparative Clinical Study to investigate, Efficacy, Safety and Tolerability of Linezolid 1200mg SR Tablet OD when compared with Linezolid 600mg Tablet BD in subjects suffering with Uncomplicated Skin and Soft Tissue Infections

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Linezolid (Primary)
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Inventia Healthcare
  • Most Recent Events

    • 29 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top